chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Metallic taste; Tired; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had the vaccine and then 30 minutes after there is a metallic taste in patient's mouth, noticed that patient had a metallic taste in mouth and was just calling to see is this a normal reaction to the vaccine because patient didn't see it anywhere in the paperwork. Patient wanted to know if that is the normal side effect because it was not listed. Patient was also tired. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
The patient received rotateq vaccine(first dose) at age 7 months. One day later he was seen in our office with fever and fussiness.  He was admitted to the hospital for 3 days to rule out bacteremia.  All cultures were negative and the only source of fever was felt to be his immunizations.  On the day he received Pediarix Prevnar and Acthib.  He had never had an adverse reaction with any of the other immunizations.  11/30/06 Received medical records from PCP which reveal patient was well on day of vax.  Seen following day with temp 103.6 & very fussy & long period of crying inconsolably.  Also found to be constipated.  Admitted to hospital w/Dx: fever, irritability, r/o sepsis. 12/8/06 Received medical records from hospital which reveal patient seen by PCP on day of vax & was well.  Then became fussy & ran fever up to 103.5 at home. Patient admitted on 9/13/06 to r/o sepsis.  Started on IV antibiotics.  Day after admission, began w/diarrhea & continued with fever.  Improved & was d/c to home on 9/16/06 still febrile & was to complete antibiotics course at home. Final Dx: gastroenteritis & febrile illness related to RotaTeq vax.
neuropathy is acting up; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Lot number was not reported) as single dose (dose number unknown) for COVID-19 immunization. Medical history included neuropathy. The patient's concomitant medications were not reported. Patient reported that she already has neuropathy but for some reason it was acting up. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Site: Pain at Injection Site-Medium, Systemic: Joint Pain-Medium, Systemic: Numbness (specify: facial area, extremities)-Medium, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-, Additional Details: Patient experiencing pain upon injection in shoulder.  Now has dull ache and numbess in the left shoulder.  Patient also reports tingling down his arm through his shoulder, elbow and ring/pinky finger.
pt woke up about 8AM w/severe pain, swelling, stiffness in hands;hand felt like the size of baseball glove;when pt stood up feet, ankles & knees had pain;
Nausea; Pain / in the hip area; nerve pain; sciatica pain; This case was reported by a consumer via call center representative and described the occurrence of nausea in a female patient who received Herpes zoster (Shingrix) (batch number K9R97, expiry date 15th November 2021) for prophylaxis.   Previously administered products included shingrix with an associated reaction of sciatica (received 1st dose on 22nd November 2019, refer case US2020082540).   In March 2020, the patient received the 2nd dose of Shingrix. In May 2020, between 2 and 3 months after receiving Shingrix, the patient experienced sciatica and nerve pain. On an unknown date, the patient experienced nausea and pain in hip. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the nausea, sciatica, pain in hip and nerve pain were unknown.   It was unknown if the reporter considered the nausea, sciatica, pain in hip and nerve pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix in March in left deltoid which resulted in nausea. The pain returned 1 week ago it was not as bad as before and was in the hip area and worse when she sits and stands. The reporter did not consent to follow up.
I thought I was having a heart attack and went to the hospital; I had an SVT event and called 911 and had an EKG in the ambulance; I was having increased heart rate and SVT after my vaccine; This is a spontaneous report from a contactable consumer consumer(patient) reported for himself that.  A 40-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number Er8727, age at vaccination 40 years), dose 1 via an unspecified route of administration, administered in Arm Right on 25Mar2021at 12:30 as 1ST DOSE, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient did not diagnose with COVID-19 Prior to vaccination. The patient did not test for COVID-19 since the vaccination. On 27Mar2021 the patient experienced 2 days after 1st dose patient stated that he had an SVT event and called 911 and had an EKG in the ambulance. They said I was not having a heart attack, but we are not surprised that I was having increased heart rate and SVT after my vaccine. I have had several since. I went to the emergency room on 13Jun2021 after another event. I thought I was having a heart attack and went to the hospital. They want to monitor me with a Holter monitor for 15 days to see if they can catch an event when it takes place. The adverse event was resulted in a visit to doctor or other healthcare professional office/clinic or Emergency room/department or urgent care. The patient underwent lab tests and procedures which included (EKG) electrocardiogram on 27Mar2021, (Holter monitor) electrocardiogram ambulatory on 13Jun2021 was unknown. The outcome of the events was not recovered.  Information on batch/lot no. are available. Further information has been requested.
Pt developed chicken pox approximately 2 weeks after having been given varicella live vaccine.
Around 5:00 pm, my son experienced labored breathing and wheezing. We administered his inhaler. The next day he felt weak and got a migraine.
Bruise at the injection site; bump at the injection site; blood at the injection site on the cotton ball; didn't feel well overall; Sore arm which got worse over the evening; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (blood at the injection site on the cotton ball), VACCINATION SITE BRUISING (Bruise at the injection site), MALAISE (didn't feel well overall), VACCINATION SITE PAIN (Sore arm which got worse over the evening) and VACCINATION SITE SWELLING (bump at the injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure fluctuation.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (blood at the injection site on the cotton ball), MALAISE (didn't feel well overall) and VACCINATION SITE PAIN (Sore arm which got worse over the evening). On 10-Mar-2021, the patient experienced VACCINATION SITE BRUISING (Bruise at the injection site) and VACCINATION SITE SWELLING (bump at the injection site). On 10-Mar-2021, VACCINATION SITE HAEMORRHAGE (blood at the injection site on the cotton ball), MALAISE (didn't feel well overall) and VACCINATION SITE PAIN (Sore arm which got worse over the evening) had resolved. At the time of the report, VACCINATION SITE BRUISING (Bruise at the injection site) and VACCINATION SITE SWELLING (bump at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products included Blood pressure medicine. No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Additional information received: Updated event outcome from  unknown to recovered for events "Bruise and bump at the injection site". Patient had declined further follow-up.
This case was reported by a pharmacist via call center representative and described the occurrence of limbs stiffness in a 54-year-old male patient who received SHINGRIX (batch number 7X743, expiry date 22nd December 2021) for prophylaxis. On 11th December 2018, the patient received the 1st dose of SHINGRIX. In December 2018, less than a week after receiving SHINGRIX, the patient experienced limbs stiffness, fever and lethargy. On an unknown date, the outcome of the limbs stiffness, fever and lethargy were unknown. It was unknown if the reporter considered the limbs stiffness, fever and lethargy to be related to SHINGRIX. Additional details were provided as follows: The patient experienced stiffness in the vaccinated arm, fever (body temperature: 100 degree F) and lethargy.
Swollen right thigh from knee-up. Started about 24 hours after immunizations on 10/4/13, resolved around 10/9/13. No treatment. Provider (PMD) notified.
Narrative:  75yo make patient deceased on 1/7/2022 at hospital. Pt was in dialysis when he passed. Pt presented to this hospital ER on 1/4/2021/ Patient self-presented to community emergency facility Emergency Notification Intake Date Presenting to the Facility: 1/4/2022 Community Care Hospital Name: Chief Complaint: Pneumonia Primary Diagnosis Patient Admitting Diagnosis: Pneumonia Community Care Provider: Acute Inpatient Care Problem list: Suspected urothelial cancer Dependence on hemodialysis due to end stage renal disease CHF - Congestive Heart Failure Legal blindness Seen by palliative care medicine serviceChronic kidney disease stage 4 Urinary incontinence Cardiac pacemaker in situ PVD-peripheral vascular disease Neuropathy due to type 2 diabetes mellitus Chronic obstructive lung disease Sleep Apnea Postraumatic stress disorder Benign essential hypertension Diabetes Mellitus Hypothyroidism Major Depressive disorder Hyperlipidemia ?Pt had received covid vaccines on 3/12/2021 & 4/9/2021 from another hospital site. Not sure id pneumonia was confirmed as diagnosis and if bacterial or if pt was covid positive since records of death at hospital.
This is a spontaneous report from a Pfizer-sponsored program. A contactable nurse reported that a 65-year-old female patient received PREVNAR 13 via unspecified route of administration on 01Aug2017 at single dose on deltoid left, given to people 65 years and above for immunization. Patient medical history included hypertension. Concomitant medication included lisinopril from unspecified date and ongoing (taken for a long time and not allergic to this medication) for hypertension. The patient had an allergic reaction to the product on unspecified date. She is experiencing redness on her arm at the injection site and would like to know how long before that goes away. Patient stated it is warm at the site. The redness is going almost around her arm and down toward her elbow. She also had flu like symptoms. The site was warm, redness around her arm and down toward her elbow, and flu-like symptoms all started 01Aug2017 in the afternoon or evening. The patient explains that her arm hurt up to her shoulder joint on 02Aug2017. She says that it is a reaction to the product. The patient took ADVIL for the pain. She also reported that it was itchy at the injection site on 05Aug2017. Outcome of the event allergic reaction was unknown. Event itchy at the injection site was not recovered; while patient was recovering from the rest of the events. The patient considered events (site was warm, redness is going almost around her arm and down toward her elbow, arm hurt up to her shoulder joint, and itchy at the injection site) to be related to pneumococcal 13-val conj vac (dipht crm197 protein).
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021 at 3:56 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 12-Feb-2021 at 3:56 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 74.68 years. No concomitant medications were reported. Batch number 031L20A  underwent temperature excursion on 12-Feb-2021 with temperature 29 degrees Fahrenheit at 9:00 AM and 35 degrees Fahrenheit from 10:00 AM to 11:00 AM. The vial was initially moved to the fridge on 09-Feb-2021 and proposed beyond use date was 10-Mar-2021. Product moved to clinic on 12-Feb-2021. 3 vials were sent to clinic. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour. No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
- hives / rash - severe back pain - migraine - nausea - blurred vision - SOB/chest tightness - heart palpitations - tachycardia - vaginal bleeding - numbness in fingers
Immediately after receiving vaccination, patient experienced tremors, tachycardia, shortness of breath. Within 30 minutes she had nausea, emesis and a strange feeling in her mouth/throat.  Patient was monitored and did not require EpiPen. She was given Benadryl. She was recommended to not have a second injection due to immediate allergic reaction. She did
My left arm around the injection spot was itchy for 3 days; My left underarm was sore and tender, it felt as if there were a few bumps; My left underarm was sore and tender, it felt as if there were a few bumps; Dose received: 3; This is a spontaneous report from a contactable reporter (consumer or other non-HCP). The reporter is the patient.  A 30-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 14Jan2022 (Lot number: FJ1620) at the age of 30 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "None", notes: Other medical history: no. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; Lot Number: FA6780; Anatomical Location: Left arm; Route of Administration: Unspecified), administration date: 28Jun2021, when the patient was 30 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE; Lot Number: FA7484; Anatomical Location: Left arm; Route of Administration: Unspecified), administration date: 26Jul2021, when the patient was 30 years old, for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 14Jan2022, outcome "unknown", described as "Dose received: 3"; VACCINATION SITE PRURITUS (non-serious) with onset 15Jan2022, outcome "recovering", described as "My left arm around the injection spot was itchy for 3 days"; AXILLARY PAIN (non-serious), AXILLARY MASS (non-serious) all with onset 15Jan2022, outcome "recovering", and all described as "My left underarm was sore and tender, it felt as if there were a few bumps". Therapeutic measures were not taken as a result of vaccination site pruritus, axillary pain and axillary mass.  Additional information: The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. It was also reported that the patient did some research on people who had experienced some lymph node swelling following the vaccine or booster. That was something not discussed as a side effect. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.
Severe muscle aches, headache and periodic shivering lasting 28 hours.  But I had both the 2nd Shingles vaccination and the quad Flu vaccine at the same time.  Not sure which caused side effects or if it was the combination.  I did not have side effects with the first shingles vaccination two months ago.
Rash on her right forearm consisting of clusters of vesicles on an erythematous base; rash is consistent with a diagnosis of herpes zoster or shingles; Radiating burning pain down the underside or volar side of her right arm to her wrist; first felt like a bruise; Radiating burning pain down the underside or volar side of her right arm to her wrist; first felt like a bruise; Pain then began to feel more like a bad sunburn with her skin being tender in the same distribution; This is a spontaneous report from a contactable healthcare professional (patient). A 30-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EK9231), via an unspecified route of administration in right arm, on 04Jan2021 at 18:15, at a single dose, for COVID-19 immunization. The patient had no medical history and concomitant medications. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The facility where the vaccine was administered was her workplace clinic. On 05Jan2021 at 03:00 PM, the patient developed radiating burning pain down the underside or volar side of her right arm to her wrist (vaccinated arm) that at first felt like a bruise within 24 hours of receiving the vaccine. In Jan2021, the pain then began to feel more like a bad sunburn with her skin being tender in the same distribution. Then on 11Jan2021, the patient developed a rash on her right forearm consisting of clusters of vesicles on an erythematous base. The patient consulted with a dermatologist in her primary care physician who agreed that the rash is consistent with a diagnosis of herpes zoster or shingles. This resulted in doctor or other healthcare professional office or clinic visit. Treatment received for shingles included valacyclovir. Post-vaccination, the patient has not been tested for COVID-19. The patient had not recovered from the events.
This spontaneous prospective pregnancy report as received from a registered nurse refers to a currently 21 years old female patient. The patient's medical history and concurrent conditions were not reported. Concomitant therapies included SYNTHROID. In approximately April 2015 (reported as about 3 weeks ago), the patient was vaccinated with an unspecified dose in series of GARDASIL. The patient was determined to be pregnant by an unspecified blood test given on an unspecified date. The patient's last menstrual period was on 10-APR-2015. Estimated date of conception was approximately 24-APR-2015 and estimated due date on 15-JAN-2016. The pregnancy outcome was outcome pending. The patient sought an unspecified type of medical attention. Additional information has been requested.
Administered COVID Booster at 1435 on 03/31/2022 to employee. Employee monitored for 15 minutes following administration and voiced no complaints. Employee Health office called 04/01/2022 by employee. Employee states she started having "throbbing" and "hot" in her shoulder around injection site around 1700. States she has also started her menses early with heavier bleeding than her normal, migraines, abdominal cramps, and body aches. Reports taking Tylenol during the evening with no relief. Advised employee to go to Urgent care or Walk-In clinic for further evaluation.
On 12/23/19, patient came in with her mother. Mother reported that "almost immediately" while sitting in the waiting room after receiving the vaccine, patient started to have numbness and tingling on the left side of her face. Mother reported that patient did not state this until they left Health Department and were in their vehicle, approximately around 3:20-3:25pm. Patient stated that her throat was "starting to close up". Mother contacted Health Department via telephone while in their vehicle at 3:38pm to report adverse event and inquired about what to do. RN stated to go to the nearest Emergency Room if Mom wanted patient to be assessed and to seek medical treatment if needed.  Follow up phone call by RN on 12/30/19 at 12:00pm: Mother stated she did not go to the Emergency Room because patient was "calming down" once they got home and patient did not appear to need emergent medical care. Mother stated that patient has history of "complex migraines" and the symptoms patient experiences with migraines were similar to the symptoms she was having after vaccination, therefore Mother was unsure if vaccine triggered complex migraine or if it was separate.   When arrived home approx. 45 minutes after leaving Health Department, mother gave patient 25 mg tablet Benadryl by mouth one time as a precaution. Mother states that patients symptoms resolved without any further medication and no other symptoms appeared.
Fever (up to 104F), malaise, muscle aches, took 48-72 hours to resolve.
This child, complained of pain in less than a few hour hours after her shot. She won't move her shoulder, no fever. Her shoulder has 7 x 6 inch red, tender, swollen area.